» Articles » PMID: 16236368

Protective Effects of Erythropoietin Against Ethanol-induced Apoptotic Neurodegenaration and Oxidative Stress in the Developing C57BL/6 Mouse Brain

Overview
Specialty Neurology
Date 2005 Oct 21
PMID 16236368
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The developing central nervous system is extremely sensitive to ethanol, with well-defined temporal periods of vulnerability. Recent studies have shown that administration of ethanol to infant rats during the synaptogenesis period triggers extensive apoptotic neurodegeneration throughout many regions of the developing brain. Furthermore, acute ethanol administration produces lipid peroxidation in the brain as an indicator of oxidative stress. In recent years, it has been shown that erythropoietin (EPO) has a critical role in the development, maintenance, protection, and repair of the nervous system. In the present study, we investigated the effect of EPO against ethanol-induced neurodegeneration and oxidative stress in the developing C57BL/6 mouse brain. Seven-day-old C57BL/6 mice were divided into three groups: control group, saline-treated group, EPO-treated group. Ethanol was administered to mice at a dosage of 2.5 g/kg for two times with a 2-h interval. Recombinant human EPO (rhEPO) was given 1000 U/kg. Twenty-four hours after the first dose of ethanol, all the animals were killed. Neuronal cell death, apoptosis, thiobarbituric acid substance (TBARS) levels, superoxide dismutase (SOD), and glutathione peroxidase (Gpx) enzymes activities were evaluated. Histopathological evaluation demonstrated that EPO significantly diminished apoptosis in the cerebellum, prefrontal cortex, and hippocampus and also spared hippocampal CA1, CA2, and CA3 neurons. Simultaneous administration of EPO along with ethanol attenuated the lipid peroxidation process and restored the levels of antioxidants. Regarding the wide use of erythropoietin in premature newborns, this agent may be potentially beneficial in treating ethanol-induced brain injury in the perinatal period.

Citing Articles

Effect of erythropoietin on SOFA score, Glasgow Coma Scale and mortality in traumatic brain injury patients: a randomized-double-blind controlled trial.

Boskabadi S, Heydari F, Mohammadnejad F, Baradari A, Moosazadeh M, Dashti A Ann Med Surg (Lond). 2024; 86(7):3990-3997.

PMID: 38989196 PMC: 11230820. DOI: 10.1097/MS9.0000000000002143.


Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series).

Molloy E, El-Dib M, Soul J, Juul S, Gunn A, Bender M Pediatr Res. 2023; 95(5):1224-1236.

PMID: 38114609 PMC: 11035150. DOI: 10.1038/s41390-023-02895-6.


Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior.

Corley C, McElroy T, Sridharan B, Trujillo M, Simmons P, Kandel S Front Neurosci. 2023; 17:1212791.

PMID: 37869506 PMC: 10587567. DOI: 10.3389/fnins.2023.1212791.


Elevated antioxidant defence in the brain of deep-diving pinnipeds.

Martens G, Folkow L, Burmester T, Gessner C Front Physiol. 2023; 13:1064476.

PMID: 36589435 PMC: 9800987. DOI: 10.3389/fphys.2022.1064476.


Efficacy and safety of high and low dose recombinant human erythropoietin on neurodevelopment of premature infants: A meta-analysis.

Qin N, Qin H Medicine (Baltimore). 2021; 100(18):e25805.

PMID: 33950982 PMC: 8104141. DOI: 10.1097/MD.0000000000025805.